Preparation of (-)-Nutlin-3 using enantioselective organocatalysis at decagram scale.


Journal article


Tyler A. Davis, A. Vilgelm, A. Richmond, J. N. Johnston
The Journal of organic chemistry, 2013

Semantic Scholar DOI PubMed
Cite

Cite

APA   Click to copy
Davis, T. A., Vilgelm, A., Richmond, A., & Johnston, J. N. (2013). Preparation of (-)-Nutlin-3 using enantioselective organocatalysis at decagram scale. The Journal of Organic Chemistry.


Chicago/Turabian   Click to copy
Davis, Tyler A., A. Vilgelm, A. Richmond, and J. N. Johnston. “Preparation of (-)-Nutlin-3 Using Enantioselective Organocatalysis at Decagram Scale.” The Journal of organic chemistry (2013).


MLA   Click to copy
Davis, Tyler A., et al. “Preparation of (-)-Nutlin-3 Using Enantioselective Organocatalysis at Decagram Scale.” The Journal of Organic Chemistry, 2013.


BibTeX   Click to copy

@article{tyler2013a,
  title = {Preparation of (-)-Nutlin-3 using enantioselective organocatalysis at decagram scale.},
  year = {2013},
  journal = {The Journal of organic chemistry},
  author = {Davis, Tyler A. and Vilgelm, A. and Richmond, A. and Johnston, J. N.}
}

Abstract

Chiral nonracemic cis-4,5-bis(aryl)imidazolines have emerged as a powerful platform for the development of cancer chemotherapeutics, stimulated by the Hoffmann-La Roche discovery that Nutlin-3 can restore apoptosis in cells with wild-type p53. The lack of efficient methods for the enantioselective synthesis of cis-imidazolines, however, has limited their more general use. Our disclosure of the first enantioselective synthesis of (-)-Nutlin-3 provided a basis to prepare larger amounts of this tool used widely in cancer biology. Key to the decagram-scale synthesis described here was the discovery of a novel bis(amidine) organocatalyst that provides high enantioselectivity at warmer reaction temperature (-20 °C) and low catalyst loadings. Further refinements to the procedure led to the synthesis of (-)-Nutlin-3 in a 17 g batch and elimination of all but three chromatographic purifications.


Share


Follow this website


You need to create an Owlstown account to follow this website.


Sign up

Already an Owlstown member?

Log in